Healthcare Health/Fitness
'Back to normal' for AstraZeneca CEO, despite Pfizer rumors
Though speculation is rife of a new Pfizer bid, AstraZeneca's chief executive is not holed up with advisers in London or New York. Instead, he has spent the last three days immersed in heart science in Barcelona.
U.S. startups get OK for smartphone-based heart tracking
For a growing U.S. aging population, tracking heart health via a smartphone can mean the difference between life and death. This week, two Silicon Valley startups received a green-light from the U.S. Food and Drug Administration for mobile applications
Johnson & Johnson to seek buyer for medical device maker unit
Johnson & Johnson (JNJ.N) plans to seek a buyer for its medical device maker business, Cordis Corp, The Wall Street Journal reported citing people familiar with the matter.
IBM launches Watson system for research, hopes for breakthroughs
International Business Machines Corp on Wednesday launched a computer system that can quickly identify patterns in massive amounts of data, an ability that IBM said should hasten breakthroughs in science and medical research.